cis-platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial
- 1 March 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (3) , 347-351
- https://doi.org/10.1016/0277-5379(84)90080-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)Cancer, 1982
- Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinumCancer Treatment Reviews, 1982
- Cis‐dichlorodiammineplatinum (II) and VP 16–213 combination chemotherapy for non‐small cell lung cancerMedical and Pediatric Oncology, 1981
- Evaluation of response criteria in advanced lung cancerCancer, 1979
- Etoposide (VP-16-213)Cancer Treatment Reviews, 1979
- VP 16-213 (VP 16) and cyclophosphamide in the treatment of primitive lung cancer in phase M ICancer, 1979
- Ergebnisse der operativen Behandlung des BronchialkarzinomsDeutsche Medizinische Wochenschrift (1946), 1976
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958